Intel is issuing a $15 billion underwritten public stock offering to fund its foundry expansion, targeting $17.25 billion with underwriters' optional purchases. The move involves banks like JPMorgan, Goldman Sachs, Morgan Stanley, and Citigroup. This reflects customer demand for AI compute and advanced packaging, areas where Intel's capacity is strained. CEO Lip-Bu Tan emphasized investing only when demand justifies it. Share dilution is estimated at 3%, aligning with post-announcement stock price drops. The funds aim to sustain Intel's competitiveness in semiconductor manufacturing without external financing.

The offering addresses Intel's need for capital in a high-cost industry. By selling stock, Intel avoids loans or external investors, relying on customer-driven growth. Emerging tech like physical AI and advanced packaging drives demand, exceeding current production limits. Underwriters can buy an extra $2.25 billion within 30 days.

Major shareholders face dilution, but the strategy prioritizes long-term relevance. Intel's focus on manufacturing expansion underscores its commitment to meeting rising AI and custom silicon needs. The company’s decision aligns with CEO Tan’s earlier stance on capacity investments tied to proven demand.

This stock sale is a strategic response to market pressures. With $15 billion at stake, Intel aims to maintain leadership in critical sectors. The scale of the offering highlights the capital-intensive nature of semiconductor R&D and production.